Market Definition
Peptides are compounds made up of two or more amino acid monomers connected by amide bonds, typically defined as having fewer than 50 amino acids. The FDA has updated its definition of biologics to include synthetic proteins with 40 to 100 amino acids and synthetic peptides with 40 amino acids or fewer. Peptides interact with specific cell surface receptors, aiding in disease therapy by targeting the cell membrane.
Request Sample: https://www.globalinsightservices.com/request-sample/GIS26136/?utm_id=1012
Market Dynamics
The global Peptide Therapeutics Market, valued at USD 42.8 billion in 2022, is projected to reach USD 74.0 billion by 2032, growing at a CAGR of 5.6%. Initially used primarily for diagnostics and hormone therapy, advancements in peptide technology have expanded their application to treat cancer and chronic metabolic disorders. Peptide-based therapies offer potential solutions to challenges faced by traditional chemotherapy, such as targeting and delivering medications effectively. Additionally, peptides are increasingly utilized in cosmeceutical treatments to combat skin aging, driven by rising consumer awareness of skincare and a desire to maintain youthful appearances, further propelling market growth.
Research Objectives
- Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS26136/?utm_id=1012
Market Segments
The report analyses the global Peptide Therapeutics Market based on application, type, type of manufacturer, route of administration, synthesis technology, and region. Based on application, the Peptide Therapeutics Market is segmented into cancer, metabolic disorders, cardiovascular disorders, respiratory disorders, gastrointestinal disorders, and others. By type, the market is classified into generic, and innovative. The innovative segment dominated the market in 2022 in terms of revenue and is expected to dominate the market during the forecast period. Based on type, the Peptide Therapeutics Market is segmented into in-house and outsourced. Based on the route of administration, the Peptide Therapeutics Market is segmented into parenteral route, oral route, pulmonary, mucosal, and others. Based on synthesis technology, the Peptide Therapeutics Market is segmented into solid-phase peptide synthesis (SPPS), liquid-phase peptide synthesis (LPPS), and hybrid technology. Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World.
Key Player
The key players studied in the global Peptide Therapeutics Market are Eli Lilly and Company, Pfizer Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, AstraZeneca, Teva Pharmaceutical Industries Ltd., Sanofi, F. Hoffmann-La Roche Ltd, Novartis AG, and Novo Nordisk A/S among others.
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS26136/?utm_id=1012
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porter 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
- Forecast Period – 2024-2033
- Base Year – 2023
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with the lead analyst of the report
- Infographic Excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after-sales service
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with the highest-quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust and transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/